ADAI News

ADAI Small Grant Supports Dissertation Research on Women, Alcohol, & Sex

Kudos! to Elizabeth Bird, UW Psychology grad student, for successfully defending her doctoral dissertation about women's use of alcohol to cope with sexual trauma and sexual distress.  Former ADAI Director Dr. Dennis M. Donovan served as her Graduate School Representative.

Dr. Bird's dissertation research was funded by a Small Grant from ADAI in 2016, "Investigation of Sexual Victimization Severity and Pre-Sex Drinking: The Roles of Sex-Related Stress and Sex-Related Drinking Motives."  She studied with psychology professor Dr. William George, who also served as a mentor on her ADAI grant.

Women ages 18-24 are at the highest risk for sexual victimization, affecting more than 20% of women during their college years, with the period of highest risk in the first year of college. This project examined the relationships among sexual violence, sex-related distress, sex-related drinking motives, and pre-sex drinking in 380 first-year college women.  Given the unique risks to physical and mental health posed by risky drinking and risky sexual behaviors, clarifying the relationship between sexual violence and pre-sex drinking might enhance addiction science, and amplify the effect of interventions targeting college students.

Mentored graduate students and post-doctoral fellows are eligible to apply for research funding from ADAI's Small Grants Program. Read more ...

ADAI Small Grants Awards for March 2019 Cycle

ADAI funded three Small Grants for the March 2019 cycle. The goal of the Small Grants Program is to stimulate research at the University of Washington by supporting promising pilot projects which may ultimately be developed into full studies with outside grant support.

Congratulations to the recipients!

• PI: Jessica R. Canning, Graduate Student, Psychology. Peer Groups and Broad Social Motives’ Influence on College Student Drinking:  A Multi-method Approach using Alcohol Administration and Daily Diary. 

  PIs: Jennifer Mankoff, PhD, Professor, Allen School of Computer Science & Engineering;  and Michele Bedard-Gilligan, PhD, Assistant Professor, Psychiatry & Behavioral Sciences. Detection and Prediction of Trauma-driven Substance Use

• PI:  Sunila Nair, PhD, Assistant Professor, Psychiatry & Behavioral Sciences.  Sex Differences in the Incubation of Cocaine Craving: Role of Ovarian Hormones  

You can read abstracts of these projects here.

The next deadline for ADAI Small Grant applications is October 15, 2019.  Read more about ADAI's Small Grants Program and application process on the Small Grant web page.

Buprenorphine Waiver Training: Upcoming Courses in WA

Health professionals! Sign up for FREE training on buprenorphine prescribing.

Completion of a 4-hour in-person course as well as a 4-hour online follow-up allows physicians to apply for the waiver to prescribe buprenorphine for office-based treatment of opioid use disorder.

ARNPs and PA-Cs require an additional 16 hours of training. CME is approved by American Academy of Addiction Psychiatry (AAAP) or American Society of Addiction Medicine (ASAM).  Other interested professionals including RNs and chemical dependency counselors may attend upon approval of the course contacts listed here.

Get details about trainings scheduled in:

• May 17, 2019 - OLYMPIA
• May 18, 2019 - COLVILLE
• May 31, 2019 - SPOKANE
• June 7, 2019 - SEATTLE

Free training is also available online: https://pcssnow.org/education-training/mat-training/.

Anytime is the Right Time: Cannabis Ad Content in Freely Distributed Magazines in King County, WA

Thursday, March 14, 2019
12:00 – 1:00 pm PDT

In this free webinar, Dr. Beatriz Carlini will present a recently concluded content analysis study that looks at how cannabis products, legal stores, and vaping devices are portrayed in print media ads and the implications of these findings for prevention and education.

Dr. Carlini is a Senior Research Scientist at the UW Alcohol & Drug Abuse Institute, and an Affiliate Associate Professor at the School of Public Health. Her research career has been dedicated to understanding the public health impact of legal psychoactive substances such as alcohol, tobacco, inhalants and more recently, marijuana.

Sponsored by Washington Healthy Youth Coalition; Washington Association for Substance Abuse and Violence Prevention; and PreventionWorksinSeattle.org

Register Here.  After registering, you will receive a confirmation email containing information about joining the webinar.

Upcoming Addiction Conferences in the Pacific NW Region

Inspiring Innovations: Behavioral Health Workforce Summit
April 3, 2019 - Spokane, WA
April 5, 2019 - Seattle, WA

The UW Evidence-Based Practice Institute (EBPI), the Advancing Integrated Mental Health Solutions (AIMS) Center, and the Integrated Care Training Program (ICTP) are sponsoring summits to explore opportunities for creating academic and industry partnerships to train the workforce of the future — a workforce prepared to deliver evidence-based treatments and increase reach to deliver access to behavioral health treatment in primary care and other non-traditional settings.

Oregon Conference on Opioids & Other Drugs, Pain & Addiction Treatment (OPAT) 2019
May 29 – 31, 2019
Riverhouse Resort, Bend, OR

***Early Bird Conference Registration ends March 31 

The 2019 OPAT conference is the must-attend event for those interested in meeting the challenge of opioids, pain and addiction. This year’s conference will be held at the Riverhouse in Bend, providing a central location that will reach interested stakeholders from around the state.

Research Society on Marijuana (RSMj), 3^rd Annual Conference
July 26-28
Vancouver, WA

*** Abstract Submission Deadline: April 15, 2019

RSMj is a network of scientists with the shared goal of promoting understanding through empirical research of the determinants, correlates, consequences, contexts, and assessment of marijuana use as well as the treatment of problematic marijuana use, including cannabis use disorder.  Keynote speakers: Alan Budney, Professor at the Geisel School of Medicine at Dartmouth, will discuss, "Communicating about Cannabis: Safe, High Risk, Therapeutic, Cannabinoids, Evidence" and Jan Copeland, Professor at the University of New South Wales, will discuss, "Cognitive Behavioral Interventions for Cannabis Use Disorder: Timing, Technologies, and the Potential for Adjunctive Cannabinoid Replacement?" 

5^th Biennial Society for Implementation Research (SIRC) Conference: Where the Rubber Meets the Road: The Intersection of Research, Policy, and Practice Sep 12-14, 2019
UW Seattle Campus

*** Abstract Submission Deadline: Mar 31, 2019

The goal of the 5th Biennial SIRC Conference is to explore ways in which research, policy and practice intersect to advance the field and improve outcomes for populations served. Where does the “rubber meet the road” and how do our advances in implementation science have a direct and relevant impact on policies and programs in real world settings?   Contact: [email protected]

*** More events:  http://adai.uw.edu/training/events.htm

SUD Clinicians & Adminstrators - Brief Survey

Dear SUD Treatment Provider or Program Administrator,

Dr. Oladunni Oluwoye at Washington State University is recruiting participants for a brief, research survey, concerning current substance use treatment, opinions about contingency management, and the use of technological-based tools for clinicians within substance use treatment. Any help passing this message on to potentially interested providers would be very much appreciated. This research is based at Washington State University and approved by WSU Institutional Review Board and is funded by the National Institute on Alcohol Abuse and Alcoholism.

Who is eligible to participate? Any current or past clinician/provider working in or with addiction services and 18 years of age or older is eligible to participate. This includes psychologists, medical doctors, mental health counselors, social workers, dependency counselors, etc. 

How long will the survey take? The survey should take no more than 25 minutes of your time.

Compensation. For completing the survey, you will be provided a $15 e-gift card.

Contact. If you have any questions about the project please contact the Primary Investigator, Dr. Oladunni Oluwoye: [email protected]

Follow this link to the survey: https://redcap.spokane.wsu.edu/surveys/?s=P897DHMY7P

 

What Is CBD and Can it Really Help Your Anxiety?

In an interview for the UW School of Medicine's Right as Rain, Dr. Bia Carlini discusses the growing popularity of CBD (cannabidiol), a compound found in marijuana.  Unlike the THC-laced joints and edibles that typically come to mind when you think of cannabis, CBD is not psychoactive, meaning it doesn’t give you the high you might get from marijuana with standard levels of THC.

Proponents say CBD can instead treat seizures that don't respond to traditional medications, and may help treat anxiety, pain and inflammation. You can find a slew of CBD-infused wellness products everywhere from recreational pot shops to your neighborhood drugstore, hair salon or spa. There are CBD oils, lotions, bath bombs, coffees, candies, and even pet treats.

According to Carlini, a senior research scientist at the UW Alcohol & Drug Abuse Institute and affiliate associate professor in the School of Public Health, “. . . when adult cannabis use was legalized in Washington in 2012, it opened a dialogue and curiosity about using a plant that was so vilified in the public. Coupled with an industry that is for-profit, and therefore very interested in mainstreaming cannabis, CBD was brought to people’s attention.”

Read "What Is CBD and Can It Really Help Your Anxiety?" by Angela Cabotaje in Right as Rain.

Help for Clinics Providing MAT Services in Washington State

The Opioid Response Network/STR-TA Consortium provides training and technical assistance to clinics and organizations implementing medication assisted treatment (MAT) for opioid use disorder. Their services are free, supported by a grant from the Substance Abuse and Mental Health Administration (SAMHSA). 

The goal of STR-TA is to streamline efforts to fill all gaps where needed and as defined by states - including Washington State. An STR-TA team assigned to every state and territory has a prevention, treatment (physician with two years’ experience treating opioid use disorders with medications), and recovery consultant. These consultants have been identified and vetted by the STR-TA Consortium. All consultants will provide evidence-based practices and resources as defined by the consortium. 

Step 1: Those seeking technical assistance should submit a request form.

Step 2: The request will be forwarded to the designated Technology Transfer Specialist (TTS) for each state/territory.

Step 3: Once the request form is submitted, the individual submitting the request will be contacted within one business day to initiate a more detailed process for understanding the request.

More information . . .

We're Hiring! Research Scientist Position at ADAI - UW

The Alcohol & Drug Abuse Institute at the University of Washington is seeking a RESEARCH SCIENTIST to work on projects related to substance use disorder, primarily opioid use disorder, as well interventions aimed at reducing substance use morbidity and mortality. While projects intersect with traditional drug treatment and health care providers, the major innovation of these projects is to engage high needs people such as those who inject drugs, are homeless, and/or are involved with the criminal justice system in settings with which they already interact.

Projects include development and testing of the impacts of interventions to reduce negative consequences of substance use disorder for high-needs clients not currently seeking substance use-related services. This includes supporting the implementation of evidence based interventions for multiple federal and state funded implementation projects across Washington State via the provision of training, technical assistance, and clinical consultation. These implementation projects could lead to future research projects for which the research scientist may pursue research grants. 

Full description & application: bit.ly/ADAI_ResScientist

Smarthone App Detects Opioid Overdose and Precursors

[UW News] A team of UW researchers have developed a cellphone app that uses sonar to monitor someone’s breathing rate and sense when an opioid overdose has occurred. The app, called Second Chance, accurately detects overdose-related symptoms about 90 percent of the time and can track someone’s breathing from up to 3 feet away. In addition to watching breathing, the app also monitors how people move.

"The idea is that people can use the app during opioid use so that if they overdose, the phone can potentially connect them to a friend or emergency services to provide naloxone,” said co-corresponding author Shyam Gollakota, an associate professor in the UW’s Paul G. Allen School of Computer Science & Engineering. “Here we show that we have created an algorithm for a smartphone that is capable of detecting overdoses by monitoring how someone’s breathing changes before and after opioid use.” 

The research to develop and test the app was funded by an ADAI Small Grant to Dr. Jacob Sunshine and by the National Science Foundation.  The team published its results in the journal Science Translational Medicine.

Read the UW News article by Sarah McQuate. and related stories in The New York Times, CNBC, Science Friday, New Atlas and Science News.